PREventing Second Cancers With DOSTARlimab

Clinical trial NCT05855811 · RECRUITING

Trial details

NCT number: NCT05855811
Sponsor: Centre Leon Berard
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cancer Primary Cancer Second Cancer

Start date: 2023-07-26
Primary completion: 2028-07-26
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.